Analysis set for each outcome and definition.

<div><p>Introduction</p><p>Neurologic or immune-mediated conditions have been evaluated as potential adverse events (AEs) in coronavirus disease 2019 (COVID-19) vaccine safety surveillance. To contextualize United States (US) surveillance findings, it is important to quantify...

Full description

Saved in:
Bibliographic Details
Main Author: Shelby S. Fisher (22676406) (author)
Other Authors: Arnstein Lindaas (22676409) (author), Stella G. Muthuri (5395769) (author), Patricia C. Lloyd (18453529) (author), Joann F. Gruber (18453535) (author), Morgan M. Richey (21253213) (author), Hai Lyu (22676412) (author), Angela S. Cheng (22676415) (author), Lisa S. Kowarski (22676418) (author), Mollie M. McKillop (9111996) (author), Christine Bui (21253201) (author), Tainya C. Clarke (12892921) (author), Jeffrey Beers (22676421) (author), Timothy Burrell (12892927) (author), Pablo Freyria Duenas (22676424) (author), Yangping Chen (16549866) (author), Minya Sheng (22676427) (author), Richard A. Forshee (18453553) (author), Steven A. Anderson (11865398) (author), Yoganand Chillarige (18453556) (author), Mary S. Anthony (13922319) (author), Azadeh Shoaibi (11060528) (author), J. Bradley Layton (9756019) (author)
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!